ES8105283A1 - Un procedimiento para la preparacion de nuevas 3-hidroxi-3- pirrolin-2, 5-dionas-4-sustituidas - Google Patents

Un procedimiento para la preparacion de nuevas 3-hidroxi-3- pirrolin-2, 5-dionas-4-sustituidas

Info

Publication number
ES8105283A1
ES8105283A1 ES492310A ES492310A ES8105283A1 ES 8105283 A1 ES8105283 A1 ES 8105283A1 ES 492310 A ES492310 A ES 492310A ES 492310 A ES492310 A ES 492310A ES 8105283 A1 ES8105283 A1 ES 8105283A1
Authority
ES
Spain
Prior art keywords
pirrolin
substituted
procedure
dionas
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES492310A
Other languages
English (en)
Spanish (es)
Other versions
ES492310A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8105283A1 publication Critical patent/ES8105283A1/es
Publication of ES492310A0 publication Critical patent/ES492310A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • C07D207/456—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES492310A 1979-06-11 1980-06-10 Un procedimiento para la preparacion de nuevas 3-hidroxi-3- pirrolin-2, 5-dionas-4-sustituidas Granted ES492310A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/047,413 US4256758A (en) 1979-06-11 1979-06-11 4-Substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase

Publications (2)

Publication Number Publication Date
ES8105283A1 true ES8105283A1 (es) 1981-05-16
ES492310A0 ES492310A0 (es) 1981-05-16

Family

ID=21948829

Family Applications (1)

Application Number Title Priority Date Filing Date
ES492310A Granted ES492310A0 (es) 1979-06-11 1980-06-10 Un procedimiento para la preparacion de nuevas 3-hidroxi-3- pirrolin-2, 5-dionas-4-sustituidas

Country Status (10)

Country Link
US (1) US4256758A (OSRAM)
EP (1) EP0021228B1 (OSRAM)
JP (1) JPS562962A (OSRAM)
AT (1) ATE1501T1 (OSRAM)
DE (1) DE3060801D1 (OSRAM)
DK (1) DK249680A (OSRAM)
ES (1) ES492310A0 (OSRAM)
GR (1) GR68727B (OSRAM)
IE (1) IE49902B1 (OSRAM)
PT (1) PT71368B (OSRAM)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428959A (en) * 1980-04-04 1984-01-31 Merck & Co., Inc. 4-Alkylsubstituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase
JPS5816528U (ja) * 1981-07-25 1983-02-01 三菱重工業株式会社 液位計
US4634717A (en) * 1984-05-01 1987-01-06 Merck & Co., Inc. Substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones, useful for treating persons with gray matter edema
US4604403A (en) * 1984-05-01 1986-08-05 Merck & Co., Inc. Use of substituted-3(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones for treating grey matter edema
US4605664A (en) * 1984-05-01 1986-08-12 Merck & Co., Inc. Use of substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones for treatment of grey matter edema
US4596821A (en) * 1984-05-01 1986-06-24 Merck & Co., Inc. Treatment of gray matter edema with 3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones
US4605663A (en) * 1984-05-01 1986-08-12 Merck & Co., Inc. Use of substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones, for treatment of grey matter edema
ES2070914T3 (es) * 1988-10-29 1995-06-16 Cadbury Schweppes Plc Agente tensioactivo.
US6353128B1 (en) * 1996-12-03 2002-03-05 Eli Lilly And Company Phenyl acetamides as sPLA2 inhibitors
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
US6903105B2 (en) * 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US20050090505A1 (en) * 2003-08-18 2005-04-28 Johnson Michael R. Methods of reducing risk of infection from pathogens
US7745442B2 (en) * 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
US20090253714A1 (en) * 2003-08-20 2009-10-08 Johnson Michael R Methods of reducing risk of infection from pathogens
EP2942349A1 (en) 2004-12-23 2015-11-11 Deciphera Pharmaceuticals, LLC Enzyme modulators and treatments
US20070021439A1 (en) * 2005-07-25 2007-01-25 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
US8188113B2 (en) 2006-09-14 2012-05-29 Deciphera Pharmaceuticals, Inc. Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
US7790756B2 (en) 2006-10-11 2010-09-07 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
JP2010524970A (ja) 2007-04-20 2010-07-22 デシフェラ ファーマシューティカルズ，エルエルシー 骨髄増殖性疾患及びその他の増殖性疾患の治療に有用なキナーゼ阻害剤
AU2009308853A1 (en) 2008-10-29 2010-05-06 Deciphera Pharmaceuticals, Llc Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
US8461179B1 (en) 2012-06-07 2013-06-11 Deciphera Pharmaceuticals, Llc Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
EP2931712B8 (en) 2012-12-17 2018-05-23 Parion Sciences, Inc. 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
SI2931713T1 (sl) 2012-12-17 2017-03-31 Parion Sciences, Inc. Derivati kloro-pirazin karboksamida uporabni za zdravljenje bolezni favoriziranih z nezadostno hidracijo sluznice
DE102013213217A1 (de) 2013-07-05 2015-01-08 Bayerische Motoren Werke Aktiengesellschaft Schließbaugruppe für einen Gepäckkoffer
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
US20200261419A1 (en) * 2015-12-07 2020-08-20 Wake Forest University Health Sciences Combinations for the treatment of kidney stones
CN107805209B (zh) * 2016-09-09 2020-11-10 中国石化扬子石油化工有限公司 一种对二乙酰苯酰胺化制备2-(4-氨基甲酰基甲基-苯基)-乙酰胺的方法
KR102708050B1 (ko) 2018-01-31 2024-09-24 데시페라 파마슈티칼스, 엘엘씨. 비만 세포증의 치료를 위한 병용 요법
WO2019152711A1 (en) 2018-01-31 2019-08-08 Diciphera Pharmaceuticals Llc. Combination therapy for the treatment of gastrointestinal stromal tumors
TWI878335B (zh) 2019-08-12 2025-04-01 美商迪賽孚爾製藥有限公司 治療胃腸道基質瘤方法
CA3150433A1 (en) 2019-08-12 2021-02-18 Deciphera Pharmaceuticals, Llc Ripretinib for treating gastrointestinal stromal tumors
FI4084778T3 (fi) 2019-12-30 2023-12-18 Deciphera Pharmaceuticals Llc Amorfisia kinaasi-inhibiittoriformulaatioita ja menetelmiä niiden käyttämiseksi
CN115243681B (zh) 2019-12-30 2024-08-16 德西费拉制药有限责任公司 1-(4-溴-5-(1-乙基-7-(甲氨基)-2-侧氧基-1,2-二氢-1,6-萘啶-3-基)-2-氟苯基)-3-苯基脲的组合物
US11779572B1 (en) 2022-09-02 2023-10-10 Deciphera Pharmaceuticals, Llc Methods of treating gastrointestinal stromal tumors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3184475A (en) * 1961-09-15 1965-05-18 Monsanto Co Maleimides, maleamides and fumaramides
US3183245A (en) * 1963-01-04 1965-05-11 Parke Davis & Co Process for the production of alpha-methyl-alpha-phenyl-beta-ethylsuccinimide
DE1445664A1 (de) * 1963-07-04 1969-11-27 Klinke Desitin Werk Verfahren zur Herstellung von alpha,alpha-disubstituierten Succinimiden
CH445487A (de) * 1963-08-05 1967-10-31 Calanda Stiftung Verfahren zur Darstellung cyclischer Imide
US3340263A (en) * 1964-02-14 1967-09-05 Ciba Geigy Corp Amino-pyrroles
US3317390A (en) * 1965-07-27 1967-05-02 American Cyanamid Co Compositions having cns depressant activity

Also Published As

Publication number Publication date
US4256758A (en) 1981-03-17
PT71368A (en) 1980-07-01
DE3060801D1 (en) 1982-10-28
DK249680A (da) 1980-12-12
IE49902B1 (en) 1986-01-08
EP0021228B1 (en) 1982-09-01
JPS562962A (en) 1981-01-13
EP0021228A1 (en) 1981-01-07
ATE1501T1 (de) 1982-09-15
GR68727B (OSRAM) 1982-02-10
IE801178L (en) 1980-12-11
ES492310A0 (es) 1981-05-16
PT71368B (en) 1981-10-21

Similar Documents

Publication Publication Date Title
ES8105283A1 (es) Un procedimiento para la preparacion de nuevas 3-hidroxi-3- pirrolin-2, 5-dionas-4-sustituidas
DK167886D0 (da) 9-(fosfonylmethoxyalkyl)adeniner, fremgangsmaade til fremstilling og brug af disse
ES2058257T5 (es) Compuestos herbicidas.
ES483511A1 (es) Un procedimiento para la preparaion de nuevas espiro-oxazo- lidinohoinas.
ES2060591T3 (es) Un procedimiento para preparar compuestos de pirazolotriazina.
ES470745A1 (es) Un procedimiento para preparar derivados de 6,6'-oxibis-pi- rona halo-sustituida
ES412587A1 (es) Procedimiento para la preparacion de nuevos compuestos bi- ciclicos nitrogenados.
ES8400110A1 (es) Procedimiento para la obtencion de derivados de benzodioxol.
ES2060079T3 (es) Procedimiento para la preparacion de un carboxialquil-eter de la 2-amino-7-hidroxitetralina.
NO870110L (no) Langkjedede alkylresorcinol-fosfitter.
ES525368A0 (es) Procedimiento para la preparacion de 6-((ciclico amino) alquilamino)tetrahidrotriazolo (3,4-a)ftalazinas
ES554827A0 (es) Procedimiento para preparar acidos hexenoicos.
ES8606376A1 (es) Procedimiento para preparar composiciones farmaceuticas a base de antibioticos de antraciclina
ES2045282T3 (es) Un procedimiento para la preparacion de antraciclinona 4-sustituida.
DE3164005D1 (en) Use of alpha-azolylglycoles as plant growth regulators
ES8201525A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,1'-bifenil-2-il-alquilamina
EP0044266A3 (en) Substituted 3,5-diamino-1,2,4-oxadiazoles and 3,5-diamino-1,2,4-thiadiazoles, their preparation and use
ES8301872A1 (es) Un procedimiento para la preparacion de nuevos derivados de 4-2-hidroxi-4(sustituido) fenil-naftalen-2-1h-onas y 2-oles.
ES8207158A1 (es) Procedimiento para la obtencion de 1-fenil-2-triazolil-1-penten-3--oles
FR2357555A1 (fr) Procede de preparation de cis-hexahydrodibenzopyranones
ES2061525T3 (es) Indoloquinoxalinas con sustituyentes en la posicion 6 que contienen grupos ciclicos.
ES8105284A1 (es) Procedimiento para preparar indolinas.
ES478361A1 (es) Un procedimiento para la produccion de compuestos que poseenactividad farmacologica como relajadores de los musculos.
FR2453181A1 (fr) Le 6-chloro-6-desoxy-mannose et son utilisation dans des compositions possedant une action inhibitrice de la fecondite masculine
FR2378782A1 (fr) Derives de diazatetracyclo-dodecanes utiles comme intermediaires de preparation

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000403